PRESS RELEASE published on 05/07/2024 at 20:04, 1 year 11 months ago EQS-Adhoc: Brockhaus Technologies AG: Significant increase in revenue by 18.5% to €39.6 million and in adjusted EBITDA by 18.0% to €11.4 million (28.7% margin) in Q1 2024 – forecast 2024 unchanged Brockhaus Technologies AG reports 18.5% revenue increase to €39.6 million and 18.0% rise in adjusted EBITDA to €11.4 million (28.7% margin) in Q1 2024. Forecast for 2024 remains unchanged Adjusted EBITDA Revenue Increase Financial Forecast Brockhaus Technologies AG Q1 2024
PRESS RELEASE published on 05/07/2024 at 20:00, 1 year 11 months ago INSTALLUX S.A. : Avis de mise à disposition de l'avis de convocation/réunion à l'AG du 11 juin 2024 et du nombre d'actions et de droits de vote Annonce de la mise à disposition de l'avis de convocation/réunion à l'Assemblée Générale Ordinaire et Extraordinaire du 11 juin 2024 et du nombre de droits de vote et d'actions composant le capital social de la société INSTALLUX cotée sur Euronext Growth Paris Euronext Capital Social Assemblée Générale Relations Investisseurs INSTALLUX
PRESS RELEASE published on 05/07/2024 at 19:30, 1 year 11 months ago JCDecaux : Assemblée Générale de JCDecaux SE du 7 mai 2024 L'Assemblée Générale de JCDecaux SE approuve les résolutions et renouvelle les mandats. Détails sur la politique de rémunération et les nominations clés. Chiffres clés de l'entreprise incluant son positionnement mondial Assemblée Générale Nominations Remuneration Chiffres Clés JCDecaux SE
PRESS RELEASE published on 05/07/2024 at 19:30, 1 year 11 months ago JCDecaux : Annual General Meeting of JCDecaux SE of 7 May 2024 JCDecaux SE AGM 2024 approves financial statements, board mandates, auditors, and executive appointments. Key figures: €3,570.0m revenue, global media leader Financial Statements AGM 2024 Board Appointments JCDecaux SE Media Leader
PRESS RELEASE published on 05/07/2024 at 19:29, 1 year 11 months ago Terms of availability of prospectuses GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
PRESS RELEASE published on 05/07/2024 at 19:29, 1 year 11 months ago Modalités de mise à disposition de prospectus GenSight Biologics annonce la mise à disposition d'un prospectus pour l'admission d'actions nouvelles sur Euronext Paris. La société spécialisée dans les thérapies géniques pour les maladies neurodégénératives informe sur le processus Euronext Paris Prospectus GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
PRESS RELEASE published on 05/07/2024 at 19:10, 1 year 11 months ago HiPay Group - Fisrt-quarter revenue 2024 HiPay reports 5% revenue growth in Q1 2024, with sustained sales growth and annual expectations confirmed. Payment volume up 3% to 2.2 billion euros Sales Revenue Growth HiPay Payment Volume Annual Expectations
PRESS RELEASE published on 05/07/2024 at 19:10, 1 year 11 months ago Ajustement de la valeur nominale Pharnext SCA annonce une réduction de capital par ajustement de la valeur nominale de ses actions. Alertes sur les financements dilutifs et conseils aux investisseurs Investisseurs Réduction De Capital Financement Dilutif Maladies Neurodégénératives Pharnext SCA
PRESS RELEASE published on 05/07/2024 at 19:00, 1 year 11 months ago Medacta announces the results of today's Annual General Meeting Medacta announces successful approval of all proposals at Annual General Meeting, including distribution of CHF 11.0 million. Dr. Alberto Siccardi re-elected as Chairman of the Board Board Of Directors Annual General Meeting Medacta Dr. Alberto Siccardi CHF 11.0 Million
PRESS RELEASE published on 05/07/2024 at 19:00, 1 year 11 months ago AS PlusPlus Capital Progresses in Restructuring Process – Application for Approval of Restructuring Plan Submitted to Court Following Investor Voting PlusPlus Capital progresses in restructuring process, submits restructuring plan for court approval after investor voting. Approval expected with extensive support from creditors PlusPlus Capital Court Approval Restructuring Process Investor Voting Creditors Support
Published on 04/23/2026 at 14:30, just now Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:00, 30 minutes ago Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 14:00, 30 minutes ago GameSquare's Stream Hatchet Publishes Q1 2026 Live Streaming Trends Report
Published on 04/23/2026 at 14:05, 25 minutes ago FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
Published on 04/23/2026 at 14:00, 30 minutes ago CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
Published on 04/23/2026 at 14:00, 30 minutes ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Published on 04/23/2026 at 13:43, 46 minutes ago clearvise optimizes portfolio by capitalizing on favorable market conditions: Successful sale of small-scale PV division
Published on 04/23/2026 at 14:18, 12 minutes ago CP Mise à disposition du rapport financier annuel 2025
Published on 04/23/2026 at 09:40, 4 hours 49 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 04/23/2026 at 08:15, 6 hours 15 minutes ago STEF : Chiffre d'affaires consolidé du 1er trimestre 2026
Published on 04/23/2026 at 08:00, 6 hours 30 minutes ago Mersen Signs A Contract with Vulcan Energy as part of Europe’s Battery industry initiative
Published on 04/23/2026 at 08:00, 6 hours 30 minutes ago Mersen signe un contrat avec Vulcan Energy dans le cadre du projet d’industrie européenne des batteries